Search Orphan Drug Designations and Approvals
-
Generic Name: | Sodium-3-((2,6-dichloro-7-fluoro-1-(1-propyl-1H-pyrazol-4-yl)-1H-indol-3-yl)thio)-2-fluorobenzoate |
---|---|
Date Designated: | 02/23/2021 |
Orphan Designation: | Treatment of Idiopathic Pulmonary Fibrosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Blade Therapeutics, Inc. 442 Littlefield Avenue South San Francisco, California 94080 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-